Publications by authors named "Ruben Gonzalez-del-Rio"

Claim this Profile
H
High-throughput screening of small molecules targeting in human iPSC macrophages.
Alejandro Armesilla-Diaz, María Pilar Arenaz, Charlotte Ashby, Delia Blanco, Emiliana D'Oria

Antimicrob Agents Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis.
Santiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, Helena I Boshoff, Joaquín Rullas

Drug Resist Updat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis.
Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, Rokeya Tasneen, Sandeep Tyagi

Antimicrob Agents Chemother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis.
Santiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, Helena Boshoff, Joaquín Rullás

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial Activity.
Uday S Ganapathy, Rubén González Del Rio, Mónica Cacho-Izquierdo, Fátima Ortega, Joël Lelièvre

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.
Dereje A Negatu, Rubén González Del Río, Mónica Cacho-Izquierdo, David Barros-Aguirre, Joël Lelievre

Antimicrob Agents Chemother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hit Compounds and Associated Targets in Intracellular .
Clement K M Tsui, Flavia Sorrentino, Gagandeep Narula, Alfonso Mendoza-Losana, Ruben Gonzalez Del Rio

Molecules· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Uday S Ganapathy, Rubén González Del Río, Mónica Cacho-Izquierdo, Fátima Ortega, Joël Lelièvre

Antimicrob Agents Chemother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline.
Christopher Burke, Monika Jankute, Patrick Moynihan, Ruben Gonzalez Del Rio, Xiaojun Li

FASEB Bioadv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.
María Pilar Arenaz-Callao, Rubén González Del Río, Ainhoa Lucía Quintana, Charles J Thompson, Alfonso Mendoza-Losana

PLoS Negl Trop Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional screening of selective mitochondrial inhibitors of Plasmodium.
Maria G Gomez-Lorenzo, Ane Rodríguez-Alejandre, Sonia Moliner-Cubel, María Martínez-Hoyos, Noemí Bahamontes-Rosa

Int J Parasitol Drugs Drug Resist· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing clinically approved cephalosporins for tuberculosis therapy.
Santiago Ramón-García, Rubén González Del Río, Angel Santos Villarejo, Gaye D Sweet, Fraser Cunningham

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery.
María Jose Rebollo-Lopez, Joël Lelièvre, Daniel Alvarez-Gomez, Julia Castro-Pichel, Francisco Martínez-Jiménez

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
Flavia Sorrentino, Ruben Gonzalez del Rio, Xingji Zheng, Jesus Presa Matilla, Pedro Torres Gomez

Antimicrob Agents Chemother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility testing for Mycobacterium sp.
Delia Blanco-Ruano, David M Roberts, Ruben Gonzalez-Del-Rio, Daniel Álvarez, Ma José Rebollo

Methods Mol Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.
Delia Blanco, Esther Perez-Herran, Mónica Cacho, Lluís Ballell, Julia Castro

Antimicrob Agents Chemother· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new molecular approach for cidal vs static antimalarial determination by quantifying mRNA levels.
Noemí Bahamontes-Rosa, Ane Rodríguez-Alejandre, Rubén González-del-Rio, José Francisco García-Bustos, Alfonso Mendoza-Losana

Mol Biochem Parasitol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis